Lipids and Lipoproteins in Atherosclerosis

Lipids and Lipoproteins in Atherosclerosis

Atherosclerosis is a chronic inflammatory disease [...]

Bibliographic Details
Main Authors:	Evgeny Bezsonov, Victoria Khotina, Victor Glanz, Igor Sobenin, Alexander Orekhov
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Biomedicines
Subjects:	n/a
Online Access:	https://www.mdpi.com/2227-9059/11/5/1424

Similar Items

Lipids and Lipoproteins in Health and Disease
by: Evgeny E. Bezsonov, et al.
Published: (2021-12-01)

Lipid Metabolism in Macrophages: Focus on Atherosclerosis
by: Vasily N. Sukhorukov, et al.
Published: (2020-08-01)

Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov
by: Victor Glanz, et al.
Published: (2022-05-01)

Macrophages in Health and Non-Infectious Disease
by: Evgeny E. Bezsonov, et al.
Published: (2021-04-01)

Macrophages in Health and Non-Infectious Disease 2.0
by: Evgeny E. Bezsonov, et al.
Published: (2022-05-01)

The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis
by: Miodrag Janić, et al.
Published: (2024-11-01)

Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development
by: Nataliya V. Mushenkova, et al.
Published: (2021-07-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response
by: Vasily N. Sukhorukov, et al.
Published: (2020-07-01)

Desialylation of Blood Plasma Lipoproteins by Exogenous Sialidase
by: Evgeny Bezsonov, et al.
Published: (2022-11-01)

Inflammation and Atherosclerosis
by: Klaus Ley
Published: (2021-05-01)

Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside
by: Alexandre Mezentsev, et al.
Published: (2021-05-01)

Oligosaccharides as Potential Therapeutics against Atherosclerosis
by: Siarhei A. Dabravolski, et al.
Published: (2023-07-01)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
by: Alexey V. Churov, et al.
Published: (2023-09-01)

NADPH Oxidases and Their Role in Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2020-07-01)

Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation
by: Sabina Ugovšek, et al.
Published: (2021-12-01)

The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment
by: Siarhei A. Dabravolski, et al.
Published: (2023-07-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
by: Josep Julve, et al.
Published: (2021-07-01)

Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis
by: Rosas, Elisabet, et al.
Published: (2016)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
by: Josep Julve, et al.
Published: (2022-03-01)

Lipoprotein (a) in atherosclerosis: A bibliometric and visualization analysis
by: Hui Wang, et al.
Published: (2023-01-01)

Lipoprotein(a): Role in atherosclerosis and new treatment options
by: Dragana Tomic Naglic, et al.
Published: (2023-07-01)

Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
by: Taisiia Shemiakova, et al.
Published: (2020-06-01)

Oxidative Stress: The Hidden Catalyst Fueling Atherosclerosis and Cardiovascular Disease
by: Lorenzo Loffredo, et al.
Published: (2024-09-01)

Editorial to the Special Issue “Molecular and Cellular Mechanisms of CVD: Focus on Atherosclerosis”
by: Nikita G. Nikiforov
Published: (2024-09-01)

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
by: Giuseppe Mandraffino, et al.
Published: (2022-06-01)

Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
by: Siarhei A. Dabravolski, et al.
Published: (2023-07-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?
by: Anastasia V. Poznyak, et al.
Published: (2023-08-01)

Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study
by: Matthew R. Deshotels, et al.
Published: (2022-11-01)

Lipid Peroxidation in Neurodegeneration
by: Consuelo Cháfer-Pericás
Published: (2021-03-01)

Translating Anti-Inflammatory Strategies for Atherosclerosis: Deep Phenotyping, Next-Generation Drug Targets, and Precision Medicine
by: Yaw Asare, et al.
Published: (2024-08-01)

Lipid Nanostructures for Antioxidant Delivery
by: Elisabetta Esposito
Published: (2022-01-01)

Modeling and Simulation of Lipid Membranes
by: Jordi Martí, et al.
Published: (2022-05-01)

Bioactive Lipids in Health and Disease
by: Monica Bari, et al.
Published: (2020-12-01)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
by: Olga I. Afanasieva, et al.
Published: (2021-06-01)

Postprandial lipoprotein metabolism and atherosclerosis.
by: Karpe, F, et al.
Published: (1995)

Atherosclerosis: cell biology and lipoproteins.
by: Karpe, F
Published: (1996)

Commentary: Lipoprotein(a) and atherosclerosis.
by: Clarke, R
Published: (2011)